Subchronic treatment with St John's wort produces a positive shift in emotional processing in healthy volunteers

被引:6
|
作者
Warren, Matthew B. [1 ]
Cowen, Philip J. [1 ,2 ]
Harmer, Catherine J. [1 ,2 ]
机构
[1] Univ Oxford, Dept Psychiat, Oxford, England
[2] Univ Oxford, Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England
关键词
St John's wort; hypericum; depression; emotional processing; TERM ANTIDEPRESSANT TREATMENT; HYPERICUM-PERFORATUM; DOUBLE-BLIND; MAJOR DEPRESSION; ATTENTIONAL BIAS; EXTRACT; PLACEBO; MEMORY; RECOGNITION; EXPRESSION;
D O I
10.1177/0269881118812101
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The neurocognitive model of antidepressant treatment in depression states that antidepressants work by producing relatively immediate positive shifts in emotional processing, which translate into clinical improvement with time. St John's Wort has shown antidepressant potential in randomised controlled trials; however, its pharmacological actions are broad and it is unknown whether treatment also produces changes in emotional processing. Aims: We investigated whether short-term treatment with St John's wort has similar effects on emotional processing to those reported with other antidepressants such as selective serotonergic reuptake inhibitors. Methods: Forty-eight healthy participants were given St John's wort or placebo treatment for seven days. On day 7 they completed a battery of tasks to measure emotional processing and other elements of cognition. Results: St John's wort treatment produced similar changes to other antidepressants, for example reducing recognition of disgusted faces and attention to fearful faces, while increasing memory for positive words. We failed to find evidence for an effect of St John's wort on other aspects of cognition including working memory. Conclusions: These findings lend support to the theory that the production of early positive biases in emotional processing may be a common feature of all clinically effective antidepressants with diverse pharmacological mechanisms.
引用
收藏
页码:194 / 201
页数:8
相关论文
共 50 条
  • [1] Effect of St. John's Wort on the pharmacokinetics of theophylline in healthy volunteers
    Morimoto, T
    Kotegawa, T
    Tsutsumi, K
    Ohtani, Y
    Imai, H
    Nakano, S
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (01): : 95 - 101
  • [2] EFFECTS OF ST. JOHN'S WORT ON THE PHARMACOKINETICS OF AMBRISENTAN IN HEALTHY VOLUNTEERS
    Markert, C.
    Kastner, I. M.
    Bauer, K.
    Mikus, G.
    Haefeli, W. E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 28 - 28
  • [3] Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers
    Burstein, AH
    Horton, RL
    Dunn, T
    Alfaro, RM
    Piscitelli, SC
    Theodore, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) : 605 - 612
  • [4] Effects of St. John's wort on tacrolimus pharmacokinetics in healthy volunteers.
    Hebert, MF
    Park, JM
    Chen, YL
    Akhtar, S
    Larson, AM
    PHARMACOTHERAPY, 2003, 23 (03): : 414 - 414
  • [5] St. John's wort reduces oral bioavailability of talinolol in healthy volunteers.
    Schwarz, UI
    Hanso, H
    Dresser, GK
    Kim, RB
    Fromm, MF
    Oertel, R
    Miehlke, S
    Kirch, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P33 - P33
  • [6] Effects of St. John's Wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers
    Hebert, ME
    Park, JM
    Chen, YL
    Akhtar, S
    Larson, AM
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (01): : 89 - 94
  • [7] St John's wort for the treatment of depression
    Shelton, RC
    LANCET NEUROLOGY, 2002, 1 (05): : 275 - 275
  • [8] St John's wort as treatment for depression
    Oppel, L
    CANADIAN FAMILY PHYSICIAN, 2002, 48 : 1290 - 1290
  • [9] Effect of St. John's wort supplementation on the pharmacokinetics of bupropion in healthy male Chinese volunteers
    Lei, H. -P.
    Yu, X. -Y.
    Xie, H. -T.
    Li, H-H
    Fan, L.
    Dai, L. -L.
    Chen, Y.
    Zhou, H. -H.
    XENOBIOTICA, 2010, 40 (04) : 275 - 281
  • [10] Agomelatine facilitates positive emotional processing in healthy volunteers
    Goodwin, G. M.
    de Bodinat, C.
    Dawson, G. R.
    Dourish, C. T.
    Waldenmaier, L.
    Adams, S.
    Cowen, P. J.
    Harmer, C. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S379 - S380